Xiang Fang1, Xinhao Wu2, Chengran Xu2

  • 1Department of Neurosurgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Frontiers in oncology
|October 8, 2025
PubMed
概括

这项研究根据缺氧基因表达确定了两个质瘤子组 (C1和C2). 在C1小组显示较差的预后和增加的基因组不稳定性,突出潜在的治疗目标,如SOCS3,CLCF1,PLAUR和LIF的脑瘤.